- Home
- SITC vs TMCI Comparison
SITC vs TMCI Comparison
Compare SITC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SITC
- TMCI
- Stock Information
- Founded
- SITC 1965
- TMCI 2014
- Country
- SITC United States
- TMCI United States
- Employees
- SITC N/A
- TMCI N/A
- Industry
- SITC Real Estate Investment Trusts
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SITC Real Estate
- TMCI Health Care
- Exchange
- SITC Nasdaq
- TMCI Nasdaq
- Market Cap
- SITC 786.5M
- TMCI 649.1M
- IPO Year
- SITC 1993
- TMCI 2021
- Fundamental
- Price
- SITC $14.61
- TMCI $9.37
- Analyst Decision
- SITC Hold
- TMCI Hold
- Analyst Count
- SITC 9
- TMCI 8
- Target Price
- SITC $38.78
- TMCI $8.84
- AVG Volume (30 Days)
- SITC 683.6K
- TMCI 405.9K
- Earning Date
- SITC 02-27-2025
- TMCI 02-27-2025
- Dividend Yield
- SITC 7.15%
- TMCI N/A
- EPS Growth
- SITC 757.51
- TMCI N/A
- EPS
- SITC 13.71
- TMCI N/A
- Revenue
- SITC $451,683,000.00
- TMCI $202,861,000.00
- Revenue This Year
- SITC N/A
- TMCI $13.27
- Revenue Next Year
- SITC N/A
- TMCI $8.61
- P/E Ratio
- SITC $1.06
- TMCI N/A
- Revenue Growth
- SITC N/A
- TMCI 16.14
- 52 Week Low
- SITC $14.47
- TMCI $3.92
- 52 Week High
- SITC $64.44
- TMCI $14.82
- Technical
- Relative Strength Index (RSI)
- SITC 40.76
- TMCI 47.42
- Support Level
- SITC $14.53
- TMCI $9.69
- Resistance Level
- SITC $14.84
- TMCI $10.30
- Average True Range (ATR)
- SITC 0.35
- TMCI 0.45
- MACD
- SITC -0.02
- TMCI -0.16
- Stochastic Oscillator
- SITC 17.18
- TMCI 3.40
About SITC SITE Centers Corp.
SITE Centers Corp is a United States-based self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.